Questionnaire survey on use of anti- allergic ophthalmic solutions for patients with seasonal allergic conjunctivitis in 2020
Not Applicable
- Conditions
- seasonal allergic conjunctivitis
- Registration Number
- JPRN-UMIN000039757
- Lead Sponsor
- Santen Pharmaceutical Co., Ltd.
- Brief Summary
We assumed that the "Proactive use" was regular ocular administration in any condition. The ratio of"Proactive use"of antihistamine eye drops was 5.1%. The ratio of "Proactive use "was significantly higher in the BID group than in the QID group(p=0.0001).
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Complete: follow-up complete
- Sex
- All
- Target Recruitment
- 1226
Inclusion Criteria
Not provided
Exclusion Criteria
Medical professionals (doctors, pharmacists, nurses, etc.) Subjects engaged in pharmaceuticals and medical devices industry Subjects engaged in pharmaceuticals distributor Subjects engaged in information provision services, research services, and advertising Subjects with severe allergic conjunctival disease (vernal keratoconjunctivitis , atopic keratoconjunctivitis)
Study & Design
- Study Type
- Others,meta-analysis etc
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method